Clinical trial · Interventional
Breathing Exercise Application in Patients With Gynecological Cancer.
The Effect of Breathing Exercise on Nausea, Vomiting and Anxiety in Patients With Gynecological Cancer Receiving Chemotherapy: Randomized Controlled Study
NCT06777225CI-TRIAL-00084750enrolling by invitationN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to determine the effects of breathing exercises on nausea, vomiting and anxiety levels in patients with gynecological cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gynecological Cancer | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| breathing exercises | Other | — | UNRESOLVED |
| scala | Other | — | UNRESOLVED |
| scale | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- experimental group
- description
- The patient was given detailed information about the research and intervention, and written consent was obtained with an informed consent form. The patient's information was obtained through a diagnostic information form containing sociodemographic information. 1st, 2nd, 3rd Cycle (The following steps were followed.) The Rhodes Nausea Vomiting and Retching Index (BCI), Beck Anxiety Scale and VAS pain scale were applied and evaluated by the researcher. The patient was directed to the room determined by the nurse in the outpatient treatment unit. Breathing exercises were applied to the patient. The patient's chemotherapy infusion was started. After the patient's chemotherapy was completed, breathing exercises were applied again. The post-test was applied. Note: The satisfaction survey was evaluated only after the 3rd cycle.
- interventionNames
- Other: breathing exercises
- Other: scale
- Other: scala
- type
- OTHER
- label
- control group
- description
- The patient was given detailed information about the research and intervention, and written consent was obtained with an informed consent form. The patient's information was obtained through a diagnostic information form containing sociodemographic information. 1st, 2nd, 3rd Course (The following steps were followed.) The researcher applied the Rhodes Nausea Vomiting and Retching Index (BCOI), Beck Anxiety Scale and VAS pain scale as a pre-test and evaluated the patient. The patient was directed to the room determined by the nurse in the outpatient treatment unit. The patient's chemotherapy was started. The post-test was applied after the chemotherapy was completed.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Being over 18 years old. * Stage 1-2-3. * Being literate. * Having volunteer patients. * Being diagnosed with gynecological cancer. * Being a female patient receiving chemotherapy for the first time. * Not smoking or consuming alcohol. * Will receive 3 cycles of chemotherapy, 21 days apart. * Not having a psychiatric diagnosis. Exclusion Criteria: * Stage 4. * Those who have been diagnosed with cancer but have not received treatment and cannot complete the cure. * Those with communication and psychiatric problems. * Those who do not know how to read, write and speak Turkish.
References
Publications (0)
Data not yet available
No reference posted for this study.